Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: An analysis of the influence of prior and current treatment factors

Quality of Life Research

Volumn 19, Issue 9, 2010, Pages 1285-1293

  Brod, Meryl ^e   Valensi, Paul ^a   Shaban, Joseph A ^b   Bushnell, Don M ^c   Christensen, Torsten L ^d  

^a UNIVERSITÉ PARIS 13   (France)

^b WINDSOR REGIONAL HOSPITAL   (Canada)

^c Health Research Associates Inc   (United States)

^d NOVO NORDISK A S   (Denmark)

^e NONE

Author keywords

Diabetes mellitus; Observational study; Treatment satisfaction

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; INSULIN ASPART;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL (TOPIC); FEMALE; HUMAN; HYPOGLYCEMIA; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; YOUNG ADULT;

EID: 78349304883     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-010-9699-0     Document Type: Article

References (45)

1. G Albrecht J Hoogstraten 1998 Satisfaction as a determinant of compliance Community Dentistry and Oral Epidemiology 26 2 139 146 1:STN:280: DyaK1czgsleitw%3D%3D 10.1111/j.1600-0528.1998.tb01940.x 9645408
2. MJ Atkinson R Kumar JC Cappelleri SL Hass 2005 Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers Value In Health 8 Suppl 1 S9 S24 10.1111/j.1524-4733.2005.00066.x 16336491
3. J Menzin C Langley-Hawthorne M Friedman L Boulanger R Cavanaugh 2001 Potential short-term economic benefits of improved glycemic control: A managed care perspective Diabetes Care 24 1 51 55 1:STN:280:DC%2BD3MzgtVaksA%3D%3D 10.2337/diacare.24.1.51 11194241
4. P Hogan T Dall P Nikolov 2003 Economic costs of diabetes in the US in 2002 Diabetes Care 26 3 917 932 10.2337/diacare.26.3.917 12610059
5. RT Anderson D Marrero SE Skovlund J Cramer S Schwartz 2003 Self-reported compliance with insulin injection therapy in subjects with type 1 and 2 diabetes [abstract] Diabetologia 46 Suppl 2 A275
6. CM Clark Jr. JW Snyder RL Meek LM Stutz CG Parkin 2001 A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction Diabetes Care 24 6 1079 1086 10.2337/diacare.24.6.1079 11375374
7. J Rosenstock JC Cappelleri B Bolinder RA Gerber 2004 Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes Diabetes Care 27 6 1318 1323 10.2337/diacare.27. 6.1318 15161782
8. Centers for Disease Control and Prevention (CDC). (2008). National Center for Health Statistics, Division of Health Interview Statistics, data from the National Health Interview Survey. Age-adjusted percentage of adults with diabetes using diabetes medication, by type of medication, United States, 1997-2008. Data computed by personnel in the Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion. http://www.cdc.gov/diabetes/statistics/meduse/fig2.htm. Accessed March 2, 2010.
9. J Meece 2006 Dispelling myths and removing barriers about insulin in type 2 diabetes The Diabetes Educator 32 9S 18S 10.1177/0145721705285638 16439485
10. JT Fitzgerald LD Gruppen RM Anderson MM Funnell SJ Jacober G Grunberger, et al. 2000 The influence of treatment modality and ethnicity on attitudes in type 2 diabetes Diabetes Care 23 313 318 1:STN:280:DC%2BD3cvntFyisw%3D%3D 10.2337/diacare.23.3.313 10868857
11. LM Hunt MA Valenzuela JA Pugh 1997 NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance Diabetes Care 20 3 292 298 1:STN:280:DyaK2s3gtlyjsQ%3D%3D 10.2337/diacare.20.3.292 9051375
12. A Zambanini RB Newson M Maisey MD Feher 1999 Injection related anxiety in insulin-treated diabetes Diabetes Research and Clinical Practice 46 3 239 246 1:CAS:528:DyaK1MXntlentrY%3D 10.1016/S0168-8227(99)00099-6 10624790
13. WH Polonsky L Fisher S Guzman L Villa-Caballero SV Edelman 2005 Psychological insulin resistance in patients with type 2 diabetes: The scope of the problem Diabetes Care 28 10 2543 2545 10.2337/diacare.28.10.2543 16186296
14. I Weijman WJ Ros GE Rutten WB Schaufeli MJ Schabracq JA Winnubst 2005 Frequency and perceived burden of diabetes self-management activities in employees with insulin-treated diabetes: relationships with health outcomes Diabetes Research and Clinical Practice 68 1 56 64 10.1016/j.diabres.2004.08.004 15811566
15. RT Anderson SE Skovlund D Marrero DW Levine K Meadows M Brod, et al. 2004 Development and validation of the insulin treatment satisfaction questionnaire Clinical Therapeutics 26 4 565 578 10.1016/S0149-2918(04)90059-8 15189754
16. M Brod D Cobden M Lammert D Bushnell P Raskin 2007 Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: Lessons learned from a clinical trial comparing biphasic and basal analogues Health and Quality of Life Outcomes 5 8 10.1186/1477-7525-5-8 17286868
17. JC Cappelleri RA Gerber IA Kourides RA Gelfand 2000 Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes Diabetes Care 23 12 1799 1803 1:STN:280:DC%2BD3M7hsVajtQ%3D%3D 10.2337/diacare.23.12.1799 11128356
18. T Petterson P Lee S Hollis B Young P Newton T Dornan 1998 Wellbeing and treatment satisfaction in older people with diabetes Diabetes Care 21 6 930 935 1:STN:280:DyaK1c3ns1Oqtg%3D%3D 10.2337/diacare.21.6.930 9614610
19. WK Redekop MA Koopmanschap RP Stolk GE Rutten BH Wolffenbuttel LW Niessen 2002 Health-related quality of life and treatment satisfaction in Dutch patients with Type 2 diabetes Diabetes Care 25 3 458 463 10.2337/diacare.25.3. 458 11874930
20. MD Taylor BM Frier AE Gold IJ Deary 2003 Psychosocial factors and diabetes-related outcomes following diagnosis of type 1 diabetes in adults: The Edinburgh Prospective Diabetes Study Diabetic Medicine 20 2 135 146 1:STN:280:DC%2BD3s%2FntFegsA%3D%3D 10.1046/j.1464-5491.2003.00887.x 12581265
21. M Franciosi A Maione B Pomili R Amoretti E Busetto F Capani, et al. 2010 Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection Nutrition, Metabolism and Cardiovascular Disease 20 1 7 14 1:STN:280:DC%2BC3c7gs1aisg%3D%3D 10.1016/j.numecd.2009.02.012
22. AB Mendes JA Fittipaldi RC Neves AR Chacra ED Moreira Jr. 2009 Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6, 671 adults with diabetes in Brazil Acta Diabetologica 10.1007/s00592-009-0138-z 19655083
23. A Biderman E Noff SB Harris N Friedman A Levy 2009 Treatment satisfaction of diabetic patients: What are the contributing factors? Family Practice 26 2 102 108 10.1093/fampra/cmp007 19254969
24. RA Gerber JC Cappelleri IA Kourides RA Gelfand 2001 Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: A randomized controlled trial Diabetes Care 24 9 1556 1559 1:STN:280:DC%2BD3MvnvV2msw%3D%3D 10.2337/diacare.24.9.1556 11522698
25. PA Hollander L Blonde R Rowe AE Mehta JL Milburn KS Hershon, et al. 2004 Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: Results of a 6-month, randomized, comparative trial Diabetes Care 27 10 2356 2362 1:CAS:528: DC%2BD2cXovFOmtbo%3D 10.2337/diacare.27.10.2356 15451900
26. T Quattrin A Bélanger NJ Bohannon SL Schwartz 2004 Exubera Phase III Study Group. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial Diabetes Care 27 11 2622 2627 1:CAS:528:DC%2BD2cXhtVKis7zN 10.2337/diacare.27.11.2622 15504996
27. P Raskin PW Bode JB Marks IB Hirsch RL Weinstein JB McGill, et al. 2003 Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24 week study Diabetes Care 26 9 2598 2603 1:CAS:528:DC%2BD3sXns1Gqu7w%3D 10.2337/diacare.26.9.2598 12941725
28. N Weintrob H Benzaquen A Galatzer S Shalitin L Lazar G Fayman, et al. 2003 Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial Pediatrics 112 3 Pt 1 559 564 10.1542/peds.112.3.559 12949284
29. U Bott S Ebrahim S Hirchberger SE Skovlund 2003 Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes Diabetes Medicine 209 8 626 634 10.1046/j.1464-5491.2003.01010.x
30. R Renner A Pfutzner M Trautmann O Harzer K Sauter R Landgraf 1999 Use of insulin lispro in continuous subcutaneous insulin infusion treatment Diabetes Care 22 5 784 788 1:STN:280:DyaK1M3msFSrtA%3D%3D 10.2337/diacare.22.5.784 10332682
31. P Valensi M Benroubi V Borzi J Gumprecht R Kawamori J Shaban, et al. 2009 Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: Safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study International Journal of Clinical Practice 63 3 522 531 1:CAS:528:DC%2BC3cXksVequ74%3D 10.1111/j.1742-1241.2009.02002.x 19187170
32. SS Ahlgren JA Shultz LK Massey BC Hicks C Wysham 2004 Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes Quality of Life Research 13 4 819 832 1:STN:280: DC%2BD2c3jtVOlsQ%3D%3D 10.1023/B:QURE.0000021694.59992.a1 15129892
33. A Nicolucci D Cucinotta S Squatrito A Lapolla N Musacchio S Leotta QuoLITy Study Group, et al. 2009 Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes Nutrition, Metabolism and Cardiovascular Disease 19 1 45 53 1:STN:280: DC%2BD1M%2FmtFSguw%3D%3D 10.1016/j.numecd.2007.12.005
34. M Brod JH Kongsø S Lessard TL Christensen 2009 Psychological insulin resistance: Patient beliefs and implications for diabetes management Quality of Life Research 18 1 23 32 10.1007/s11136-008-9419-1 19039679
35. BH Wolffenbuttel CH Drossaert AP Visser 1993 Determinants of injecting insulin in elderly patients with type II diabetes mellitus Patient Education and Counseling 22 3 117 125 1:STN:280:DyaK2c3gtl2iug%3D%3D 10.1016/0738-3991(93) 90091-A 8153033
36. KS Bryden A Neil RA Mayou RC Peveler CG Fairburn DB Dunger 1999 Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes Diabetes Care 22 12 1956 1960 1:STN:280:DC%2BD3c%2FlsFWgtQ%3D%3D 10.2337/diacare.22.12.1956 10587825
37. WH Polonsky BJ Anderson PA Lohrer JE Aponte AM Jacobson CF Cole 1994 Insulin omission in women with IDDM Diabetes Care 17 10 1178 1185 1:STN:280:DyaK2M7itFWhtw%3D%3D 10.2337/diacare.17.10.1178 7821139
38. J Albu N Raja-Khan 2003 The management of the obese diabetic patient Primary Care: Clinics in Office Practice 30 2 465 491 10.1016/S0095-4543(03) 00043-5 14567159
39. F Alvarez Guisasola S Tofé Povedano G Krishnarajah R Lyu P Mavros D Yin 2008 Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: Findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obesity and Metabolism 10 Suppl 1 25 32 10.1111/j.1463-1326.2008.00882.x
40. M Brod SE Skovlund KU Wittrup-Jensen 2006 Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience Quality of Life Research 15 3 481 491 10.1007/s11136-005- 1624-6 16547787
41. M Brod T Christensen JH Kongso DM Bushnell 2009 Examining and interpreting responsiveness of the Diabetes Medication Satisfaction measure Journal of Medical Economics 12 4 309 316 10.3111/13696990903337017 19811109
42. D Wild A Grove M Martin S Eremenco S McElroy A Verjee-Lorenz, et al. 2005 Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation Value in Health 8 2 94 104 10.1111/j.1524-4733.2005.04054.x 15804318
43. L Ring S Hofer F Heuston D Harris CA O'Boyle 2005 Response shift masks the treatment impact on patient reported outcomes (PROs): The example of individual quality of life in edentulous patients Health and Quality of Life Outcomes 7 3 55 10.1186/1477-7525-3-55
44. LS Matza KS Boye N Yurgin J Brewster-Jordan S Mannix JM Shorr, et al. 2007 Utilities and disutilities for type 2 diabetes treatment-related attributes Quality of Life Research 16 7 1251 1265 10.1007/s11136-007-9226-0 17638121
45. P Valensi M Benroubi V Borzi J Gumprecht R Kawamori J Shaban, et al. 2008 IMPROVE Study Group Expert Panel: The IMPROVE TM study-a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts International Journal of Clinical Practice 62 11 1809 1819 1:STN:280:DC%2BD1M%2FntVGlsg%3D%3D 10.1111/j.1742-1241.2008.01917.x 18811598